Valo Therapeutics Oy
🇫🇮Finland
- Country
- 🇫🇮Finland
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.valotx.com
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
Phase 1
Recruiting
- Conditions
- Melanoma (Skin)Triple-Negative Breast CancerNon-Small Cell Lung CancerSynovial SarcomaMyxoid LiposarcomaColorectal CancerOsteosarcomaSarcoma
- Interventions
- First Posted Date
- 2022-08-08
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Valo Therapeutics Oy
- Target Recruit Count
- 15
- Registration Number
- NCT05492682
- Locations
- 🇩🇪
Krankenhaus Nordwest, Frankfurt, Germany
🇩🇪National Center for Tumor Diseases, Heidelberg, Germany
🇩🇪Universitätsklinikum Tübingen, Tübingen, Germany
© Copyright 2025. All Rights Reserved by MedPath